共 50 条
The Role of IFN-alpha in Experimental and Clinical Uveitis
被引:2
作者:
Liu, Xiaoli
[1
]
Diedrichs-Moehring, Maria
[1
]
Wildner, Gerhild
[1
]
机构:
[1] Klinikum Univ Munchen, Dept Ophthalmol, Immunobiol Sect, Mathildenstr 8, D-80336 Munich, Germany
关键词:
NK cells;
rat experimental autoimmune uveitis;
regulatory T cells;
Th1;
Th17;
EXPERIMENTAL AUTOIMMUNE UVEORETINITIS;
REGULATORY T-CELLS;
ENDOTHELIAL GROWTH-FACTOR;
HUMAN RECOMBINANT INTERFERON-ALPHA-2A;
IL-1 RECEPTOR ANTAGONIST;
BEHCETS-DISEASE PATIENTS;
LONG-TERM EFFICACY;
MONONUCLEAR-CELLS;
DENDRITIC CELLS;
VIRUS-INFECTION;
D O I:
10.1080/09273948.2017.1298822
中图分类号:
R77 [眼科学];
学科分类号:
100212 ;
摘要:
Purpose: IFN-alpha is the only treatment capable of inducing long-term remission in some patients with ocular Behcet's disease. In this review, we focus on immune mechanisms of IFN-alpha in animal models and patients and compare the outcome of different clinical studies. Methods: Review of literature using PubMed and Google and original data from rat models with monophasic/chronic or relapsing experimental autoimmune uveitis treated with IFN-alpha. Results: The role of IFN-alpha and its effect on various cell types were investigated, in some cases with contradictory results. Some patients respond very well to IFN-alpha treatment, while others are non-responders, which was reflected in the uveitis rat models: relapsing uveitis was ameliorated, the monophasic/chronic disease even aggravated. Conclusions: Despite intensive investigations in patients and animal models, the immune mechanisms explaining the therapeutic effect of IFN-alpha in ocular Behcet's disease are not yet fully understood and need further investigation.
引用
收藏
页码:23 / 33
页数:11
相关论文
共 50 条